
Chapter 17 EMC tables
Rated
maximum
output
power of
transmitter
[W]
Separation distance according to frequency of transmitter
[m]
150 kHz to
80 MHz
outside ISM
bands
d=0,35
√
P
150 kHz to
80 MHz in
ISM bands
d=1,2
√
P
80 MHz to
800 MHz
d = 0.4
√
P
800 MHz
to
6 GHz
d = 0.77
√
P
0.01
0.04
0.12
0.04
0.08
0.1
0.11
0.38
0.13
0.24
1
0.4
1.2
0.4
0.8
10
1.11
3.8
1.3
2.4
100
3.5
12
4
7.7
For transmitters rated at a maximum output power not listed above, the
recommended separation distance
d
in metres [m] can be determined using the
equation applicable to the frequency of the transmitter, where
P
is the maximum
output power rating of the transmitter in watts [W] according to the transmitter
manufacturer.
Tab. 17-4
Separation distance depending on frequency of transmitter
NOTE 1
At 80 MHz and 800 MHz, the separation distance for the higher fre
quency range applies.
NOTE 2
The ISM (industrial, scientific and medical) bands between 150 kHz
and 80 MHz are 6.765 MHz to 6.795 MHz; 13.553 MHz to 13.567
MHz; 26.957 MHz to 27.283 MHz; and 40.66 MHz to 40.70 MHz.
NOTE 3
An additional factor of 10/3 has been incorporated into the formulae
used in calculating the recommended separation distance for trans
mitters in the ISM frequency bands between 150 kHz and 80 MHz
and in the frequency range 80 MHz to 2.5 GHz to decrease the like
lihood that mobile/portable communications equipment could cause
interference if it is inadvertently brought into patient areas.
NOTE 4
These guidelines may not apply in all situations. Electromagnetic
propagation is affected by absorption and reflection from structures,
objects and people.
1000721x09 Revision 8
235
Содержание EXCOR Pediatric VAD
Страница 2: ...This page was left blank intentionally 1000721x09 Revision 8 ...
Страница 4: ...This page was left blank intentionally 1000721x09 Revision 8 ...
Страница 43: ...Chapter 3 Summary of Clinical Studies Tab 3 5 Demographic data summary a 1000721x09 Revision 8 33 ...
Страница 76: ...Chapter 5 Description Ikus This page was left blank intentionally 1000721x09 Revision 8 66 ...
Страница 102: ...Chapter 6 Instructions for use Ikus This page was left blank intentionally 1000721x09 Revision 8 92 ...
Страница 142: ...Chapter 9 Implantation surgical procedure This page was left blank intentionally 1000721x09 Revision 8 132 ...
Страница 162: ...Chapter 12 Anticoagulation therapy This page was left blank intentionally 1000721x09 Revision 8 152 ...
Страница 200: ...Chapter 14 Error Messages and corrective measures This page was left blank intentionally 1000721x09 Revision 8 190 ...
Страница 220: ...Chapter 15 Troubleshooting and correcting faults This page was left blank intentionally 1000721x09 Revision 8 210 ...
Страница 231: ...Chapter 16 Appendix 16 4 Sample copy Ikus Incoming Checklist 1000721x09 Revision 8 221 ...
Страница 232: ...Chapter 16 Appendix 16 5 Implantation record form 1000721x09 Revision 8 222 ...
Страница 233: ...Chapter 16 Appendix 1000721x09 Revision 8 223 ...
Страница 234: ...Chapter 16 Appendix 1000721x09 Revision 8 224 ...
Страница 235: ...Chapter 16 Appendix 1000721x09 Revision 8 225 ...
Страница 236: ...Chapter 16 Appendix 1000721x09 Revision 8 226 ...
Страница 239: ...Chapter 16 Appendix 1000721x09 Revision 8 229 ...
Страница 240: ...Chapter 16 Appendix 16 7 Pump performance flow sheet 1000721x09 Revision 8 230 ...
Страница 246: ...Chapter 17 EMC tables This page was left blank intentionally 1000721x09 Revision 8 236 ...